Protein-based Biointerfaces to Control Stem Cell Differentiation - Biointerfaces: Where Material Meets Biology - page 25

19. T. Zako, et al., Cyclic RGD peptide-labeled upconversion nanophos-
phors for tumor cell-targeted imaging, Biochem. Biophys. Res. Commun.,
2009, 381(1), 54-58.
20. F. Danhier, et al., Targeting of tumor endothelium by RGD-grafted
PLGA-nanoparticles loaded with Paclitaxel, J. Controlled Release, 2009,
140(2), 166-173.
21. B. D. Ratner and S. J. Bryant, Biomaterials: Where we have been and
where we are going, Annu. Rev. Biomed. Eng., 2004, 6, 41-75.
22. D. J. Gorth, et al., Decreased bacteria activity on Si(3)N(4) surfaces
compared with PEEK or titanium, Int. J. Nanomed., 2012, 7, 4829-4840.
23. S. L. Bellis, Advantages of RGD peptides for directing cell association
with biomaterials, Biomaterials, 2011, 32(18), 4205-4210.
24. A. Meyer, et al., Targeting RGD recognizing integrins: drug develop-
ment, biomaterial research, tumor imaging and targeting, Curr. Pharm.
Des., 2006, 12(22), 2723-2747.
25. Y. Takada, X. Ye and S. Simon, The integrins, Genome Biol., 2007,
8(5), 215.
26. A. Rezania and K. E. Healy, Integrin subunits responsible for adhesion
of human osteoblast-like cells to biomimetic peptide surfaces,
J. Orthop. Res., 1999, 17(4), 615-623.
27. S. Rammelt, et al., Coating of titanium implants with type-I collagen,
J. Orthop. Res., 2004, 22(5), 1025-1034.
28. M. Horton, Vitronectin receptor: tissue specific expression or adap-
tation to culture?, Int. J. Exp. Pathol., 1990, 71(5), 741-759.
29. M. J. P. Biggs, et al., Regulation of implant surface cell adhesion:
Characterization and quantification of S-phase primary osteoblast ad-
hesions on biomimetic nanoscale substrates, J. Orthop. Res., 2007,
25(2), 273-282.
30. D. Pan, J. L. Turner and K. L. Wooley, Folic acid-conjugated nano-
structured materials designed for cancer cell targeting, Chem. Commun.,
2003, 2400-2401.
31. S. Kim, et al., Engineered polymers for advanced drug delivery, Eur. J.
Pharm. Biopharm., 2009, 71(3), 420-430.
32. Y. Teow and S. Valiyaveettil, Active targeting of cancer cells using folic acid-
conjugated platinum nanoparticles, Nanoscale, 2010, 2(12), 2607-2613.
33. S. Fuchs and C. Coester, Protein-based nanoparticles as a drug delivery
system: chances, risks, perspectives, J. Drug Delivery Sci. Technol., 2010,
20(5), 331-342.
34. T. Matsuura, et al., Diverse mechanisms of osteoblast spreading on
hydroxyapatite and titanium, Biomaterials, 2000, 21(11), 1121-1127.
35. B. Elmengaard, J. E. Bechtold and K. Soballe, In vivo study of the effect
of RGD treatment on bone ongrowth on press-fit titanium alloy im-
plants, Biomaterials, 2005, 26(17), 3521-3526.
36. M. C. Port´-Durrieu, et al., Cyclo-(DfKRG) peptide grafting onto Ti-6Al-
4V: physical characterization and interest towards human osteopro-
genitor cells adhesion, Biomaterials, 2004, 25(19), 4837-4846.

d n 3 r 4 n g | 1

.